Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Neuroscience. 2010 Sep 9;171(2):566–576. doi: 10.1016/j.neuroscience.2010.08.058

Figure 4.

Figure 4

δV1-1 provides neuroprotection in the cortex regions 7 days after ACA. Rats pretreated with δV1-1 or tat peptide were subjected to 6 min of ACA. Since cortical CBF was measured throughout this study (via 2-PM method), we determined the number of dead cortical neurons in the same region as CBF measurements. Rats pretreated with δV1-1 presented with lower number of dead cortical neurons as compared to no drug and tat peptide experimental groups after ACA (n = 3 – 11, * p ≤ 0.05).